Drug Delays Worsening of Newly Diagnosed Pulmonary Arterial Hypertension

(Medage today) – For recently diagnosed pulmonary hypertension (HAP), the addition of SotaterCeppt (Winrevair) to standard care reduced the risk of clinical worsening, the randomized hyperion trial has shown. Among 320 patients, at least one primary …